Skip to main content
Caplight Logo









AgPlus Diagnostics

AgPlus Diagnostics

Private
SharnbrookHealthcare & Life Scienceshttps://agplusdiagnostics.com

Last Round

Grant

Sep 10, 2020

Total Funding Raised

$1.19M

Company Overview

AgPlus Diagnostics is a biotechnology company that develops portable point-of-care diagnostic platforms using patented electrochemical immunoassay technology.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Sensors

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Usage-Based SaaS

AI Layer

Non-AI

Keywords

point-of-care diagnosticsPOC testingelectrochemical immunoassaymicrofluidic cartridgesdiagnostic devicecontract assay developmentmedical device manufacturingbiosensor technologyOEM manufacturinghandheld diagnosticslab-on-a-chipveterinary diagnosticsenvironmental testingrapid testing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AgPlus Diagnostics Comparables

Compare AgPlus Diagnostics with similar companies based on industry and business-model similarity.

AgPlus Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Proxim Diagnostics Corp.
82%
Attomarker Ltd
80%
Osler Diagnostics
77%

AgPlus Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 10, 2020
GrantJun 4, 2020
GrantMar 6, 2019
SeedSep 28, 2016

AgPlus Diagnostics Investors

Notable investors and investment history

AgPlus Diagnostics investors
InvestorRounds
Innovate UKGrant
UK Innovation & Science Seed FundGrant
Defence and Security AcceleratorGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 4, 2020

    $60K grant received from Innovate UK.

  • Mar 6, 2019

    $900K raised from Innovate UK and UK Innovation & Science Seed Fund.

AgPlus Diagnostics Filings

Explore SEC and related filing metadata, where available.

AgPlus Diagnostics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AgPlus Diagnostics's valuation, stock price, and market status.

Is AgPlus Diagnostics a public or private company?

AgPlus Diagnostics is a private company.

What is the current stock price of AgPlus Diagnostics?

AgPlus Diagnostics is a private company, so its shares have no public market price. Caplight tracks AgPlus Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is AgPlus Diagnostics worth (valuation)?

Valuation information for AgPlus Diagnostics is not publicly available.

Can I buy AgPlus Diagnostics stock?

AgPlus Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was AgPlus Diagnostics's last funding round?

AgPlus Diagnostics's most recent funding round was Grant on September 10, 2020.

Who are the main investors in AgPlus Diagnostics?

Key investors in AgPlus Diagnostics include Innovate UK, Defence and Security Accelerator.

Will AgPlus Diagnostics IPO soon?

No public IPO plans have been announced for AgPlus Diagnostics.

How can I track AgPlus Diagnostics secondary market activity?

Caplight tracks bids, offers, and trades in AgPlus Diagnostics's shares on secondary markets.

Firmographic Details

HeadquartersSharnbrook
Employee Range6
Year Founded2011
Last FundingSep 10, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?